Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Is a Potential TikTok Ban the Next Big Catalyst for BBIG Stock?

Speculators are eyeballing an intriguing case for BBIG stock as rival ByteDance’s TikTok platform comes under political fire.

Why Michael Burry Sees Tesla’s Autopilot Layoffs as a Labor Market Alarm

Michael Burry is again sounding the alarm on the economy. This time, he’s worried about a bifurcated labor market.

PFE Stock Rises as Pfizer Requests FDA Approval of Covid-19 Treatment Paxlovid

PFE stock is up in afternoon trading as Pfizer enjoys a double round of positive news regarding its Covid-19 drugs.

Airbnb (ABNB) Stock Slumps After Analyst Slashes Price Target

JPMorgan Chase downgraded its price target for ABNB stock and it’s not the only institution that’s skeptical about Airbnb.

7 Cryptos to Watch Closely as Investors Strategize Next Moves

While cryptos have finally found a stabilizing line recently, investors ought to be careful during this very awkward setup.

Dear MULN Stock Fans, Mark Your Calendars for June 30

Although the EV sector has run into potholes this year, fans of MULN stock should wait for June 30 when important info could be released.

BBIG Stock Falls 5% on the Cryptyde Spinoff Distribution Date

On the day of Vinco Venture’s stock distribution for spinoff Cryptyde, BBIG stock dropped 5%, raising eyebrows among investors.

Akebia Therapeutics (AKBA) Stock Soars 18% Despite Lack of News

AKBA stock is up big, but the lack of news is concerning considering that Akebia Therapeutics already faces a regulatory setback.

GIS Stock Pops as General Mills Announces Dividend Raise

Although the rest of the market got off to a mixed start, GIS stock is killing it thanks to General Mills’ impressive earnings report.

7 Warren Buffett Stocks to Buy for a Bear Market

Faced with sharp losses in equities, investors may be best served following the Warren Buffett stocks to buy for a bear market.